×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HUMA – humacyte, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HUMA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/2
08:28 am
huma
Humacyte To Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Humacyte To Participate in Upcoming Investor Conferences [Yahoo! Finance]
3/2
08:00 am
huma
Humacyte To Participate in Upcoming Investor Conferences
Low
Report
Humacyte To Participate in Upcoming Investor Conferences
2/19
08:23 am
huma
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $25.00 price target on the stock.
Medium
Report
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $25.00 price target on the stock.
2/18
08:00 am
huma
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
Low
Report
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
2/18
03:27 am
huma
Humacyte (HUMA) Valuation Check As DoD Funding Highlights Symvess Battlefield Trauma Potential [Yahoo! Finance]
Medium
Report
Humacyte (HUMA) Valuation Check As DoD Funding Highlights Symvess Battlefield Trauma Potential [Yahoo! Finance]
2/9
06:09 pm
huma
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at BTIG Research.
High
Report
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at BTIG Research.
2/9
05:10 pm
huma
Humacyte: Positive News For Symvess At Last, But Long-Term Threats Persist [Seeking Alpha]
High
Report
Humacyte: Positive News For Symvess At Last, But Long-Term Threats Persist [Seeking Alpha]
2/9
02:45 pm
huma
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $25.00 price target on the stock.
Low
Report
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $25.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/9
11:43 am
huma
Form SCHEDULE 13D/A Humacyte, Inc. Filed by: Fresenius Medical Care AG
Low
Report
Form SCHEDULE 13D/A Humacyte, Inc. Filed by: Fresenius Medical Care AG
12/16
05:31 pm
huma
Form 8-K Humacyte, Inc. For: Dec 16
Medium
Report
Form 8-K Humacyte, Inc. For: Dec 16
12/15
04:52 pm
huma
Form 8-K Humacyte, Inc. For: Dec 15
Medium
Report
Form 8-K Humacyte, Inc. For: Dec 15
12/15
09:12 am
huma
Form 8-K Humacyte, Inc. For: Dec 15
High
Report
Form 8-K Humacyte, Inc. For: Dec 15
12/8
02:20 pm
huma
Form 4 Humacyte, Inc. For: Aug 26 Filed by: FRESENIUS MEDICAL CARE HOLDINGS INC /NY/
Low
Report
Form 4 Humacyte, Inc. For: Aug 26 Filed by: FRESENIUS MEDICAL CARE HOLDINGS INC /NY/
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: